Clinical Trials Browser

INDUSTRY × Lymphoma × avelumab × Clear all

NCT03451825 2024-06-24

Phase I/II Study of Avelumab in Pediatric Cancer Participants

Phase 1 Terminated

21 enrolled 21 charts

Lymphoma, Central Nervous System Neoplasms